Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Phase 1 Completed 31 enrolled Dana-Farber Cancer Institute National Cancer Institute (NCI) · collab

NaSingle-groupOpen-labelTreatment

Summary

Phase I trial to study the effectiveness of docetaxel plus radiation therapy in treating patients who have stage III or stage IV head and neck cancer.

Timeline

Start: 2000-07-14
Primary completion: 2003-07-17
Completion: 2004-07-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Docetaxel	Small molecule	—	Intravenous

Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Summary

Timeline

Drugs

Indications